NCT/Study#

NCT04458831 /

IONA OBS16577

A prospective, non-interventional, multinational, observational study with isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM)

A prospective, non-interventional, multinational, observational study with isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM)

DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Accepting Patients
Location:
Freehold, NJ, Howell, NJ, Little Silver, NJ
For More information: